MEDICLIN AG/ DE0006595101 /
| 2024-11-15 5:36:23 PM | Chg. 0.000 | Volume | Bid2024-11-15 | Ask2024-11-15 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 2.640EUR | 0.00% | 2,775 Turnover: 7,159.520 |
-Bid Size: - | -Ask Size: - | 118.75 mill.EUR | - | - |
Assets
|
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 617.5000 | 572 | 508.3000 | 543.9380 | 514.3780 | ||||||
| Intangible Assets | 8.9000 | 8.8000 | 7 | 5.6650 | 6.1150 | ||||||
| Long-Term Investments | .9000 | .9000 | .8000 | - | - | ||||||
| Fixed Assets | 731.8000 | 683.6000 | 615.3000 | 654.1030 | 580.6750 | ||||||
| Inventories | 8.1000 | 9.3000 | 8.5000 | 8.8690 | 7.2960 | ||||||
| Accounts Receivable | 101.1000 | 76.3000 | 81.2000 | 88.4890 | 81.5810 | ||||||
| Cash and Cash Equivalents | 37.2000 | 100.4000 | 119.5000 | 88.0390 | 115.2850 | ||||||
| Current Assets | 166 | 203.9000 | 265.9000 | 262.0080 | 299.8260 | ||||||
| Total Assets | 897.8000 | 887.5000 | 881.2000 | 916.1110 | 880.5010 | ||||||
Liabilities
|
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 17.6000 | 11.3000 | 13 | 14.4950 | 12.6260 | ||||||
| Long-term debt | 472.2000 | 444.3000 | 397.6000 | 67.5420 | 66.4180 | ||||||
| Liabilities to Banks | 564.8000 | 542.8000 | 514.7000 | - | - | ||||||
| Provisions | 99.6000 | 107.7000 | 98.6000 | 52.8330 | 29.7730 | ||||||
| Liabilities | 707.1000 | 710.7000 | 698.2000 | 706.7890 | 684.4720 | ||||||
| Share Capital | 47.5000 | 47.5000 | 47.5000 | - | - | ||||||
| Total Equity | 190.7000 | 176.8000 | 183 | 209.2060 | 195.9170 | ||||||
| Minority Interests | -.2000 | -.3000 | -.3000 | .1150 | .1110 | ||||||
| Total liabilities equity | 897.8000 | 887.5000 | 881.2000 | 916.1110 | 880.5010 | ||||||
Income Statement
|
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 673.1000 | 659.9000 | 673.1000 | 704.6960 | 730.0710 | ||||||
| Depreciation (total) | 71.2000 | 77.3000 | 73.7000 | 71.4040 | 86.0050 | ||||||
| Operating Result | 22.4000 | .2000 | 11.6000 | 19.5190 | 12.7210 | ||||||
| Interest Income | -10.8100 | -10.2500 | -9.2500 | -9.7430 | -21.4100 | ||||||
| Income Before Taxes | 11.6000 | -10.1000 | 2.4000 | 9.7770 | -8.6880 | ||||||
| Income Taxes | 1.9000 | -1.1000 | 1 | .0580 | 2.0350 | ||||||
| Minority Interests Profit | -.0200 | .0400 | -.0200 | .2780 | .0520 | ||||||
| Net Income | 9.7000 | -9 | 1.5000 | 9.4400 | -10.7760 | ||||||
Per Share
Cash Flow
|
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 69.6000 | 118.7000 | 82 | 34.6390 | 78.0010 | ||||||
| Cash Flow from Investing Activities | -35.6000 | -8.6000 | -7.1000 | -6.2420 | -9.5110 | ||||||
| Cash Flow from Financing | -30.5000 | -46.5000 | -55.3000 | -56.1710 | -45.4790 | ||||||
| Decrease / Increase in Cash | 3.4000 | 63.2000 | 19.6000 | - | - | ||||||
| Employees | 7,323 | 7,349 | 7,115 | 7,025 | 7,016 | ||||||
